TGF-beta signal transduction in chronic kidney disease

H William Schnaper1, Sara Jandeska, Constance E Runyan

  • 1Division of Kidney Diseases, Department of Pediatrics, Northwestern University Feinberg School of Medicine, 303 E Chicago Ave.; Chicago, IL 60611-3008, USA. Schnaper@northwestern.edu

Insights

Transforming growth factor-beta (TGF-beta) drives chronic kidney disease through complex signaling pathways. Understanding these mechanisms offers potential therapeutic targets for renal dysfunction.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Signaling

Background:

  • Transforming growth factor-beta (TGF-beta) is a key mediator in chronic progressive kidney disease.
  • TGF-beta influences critical cellular processes including proliferation, hypertrophy, apoptosis, and fibrogenesis.
  • The diverse effects of TGF-beta suggest intricate regulatory mechanisms governing its signaling.

Purpose of the Study:

  • To review the multifaceted mechanisms regulating TGF-beta signaling in the kidney.
  • To elucidate the role of TGF-beta in the pathogenesis of renal dysfunction.
  • To explore potential therapeutic strategies targeting TGF-beta pathways.

Main Methods:

  • Review of studies on TGF-beta signaling pathways in kidney cells.
  • Analysis of findings from whole-animal experimental models of kidney disease.
  • Examination of regulatory steps from TGF-beta availability to nuclear signaling.

Main Results:

  • TGF-beta signaling is tightly regulated at multiple levels, including ligand availability, receptor interactions, and Smad protein activity.
  • Dysregulation of TGF-beta signaling contributes significantly to kidney disease progression.
  • Interactions between Smad proteins and other signaling pathways are crucial for nuclear responses.

Conclusions:

  • TGF-beta signaling is a central driver of chronic kidney disease pathogenesis.
  • Targeting specific components of the TGF-beta pathway holds promise for treating renal dysfunction.
  • Further research into these complex mechanisms is essential for developing effective therapies.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Glomerular Filtration Rate and its Regulation01:28

Glomerular Filtration Rate and its Regulation

The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...